Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 81.79

-3.0%

Feb 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rob J who wrote (1804)	3/17/1998 8:23:00 AM
From: sds	Read Replies (1) of 4676

Why? It's called full disclosure. Isis has to tell the FDA about it, and if an investor did a FOIA (Freedom of Info. Act) search of Isis filings with the FDA, they would eventually find that. Then, everyone would be asking why Isis "covered it up". I like companies that admit to all of their problems and generally keep the good news to themselves -- those are the stocks that are ultimately big winners. This is a minor issue (hell, he wasn't even an Isis researcher), but Isis acted responsibly in issuing the press release. Imagine what an Isis short could have done with this one.... sds

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next